(19)
(11) EP 2 941 250 A1

(12)

(43) Date of publication:
11.11.2015 Bulletin 2015/46

(21) Application number: 13840277.1

(22) Date of filing: 26.09.2013
(51) International Patent Classification (IPC): 
A61K 31/44(2006.01)
A61K 31/4439(2006.01)
A61K 9/48(2006.01)
A61K 31/415(2006.01)
A61K 9/20(2006.01)
(86) International application number:
PCT/US2013/061972
(87) International publication number:
WO 2014/052625 (03.04.2014 Gazette 2014/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 04.01.2013 US 201361749197 P

(71) Applicant: Levetan, Claresa
Bryn Mawr, PA 19010 (US)

(72) Inventor:
  • Levetan, Claresa
    Bryn Mawr, PA 19010 (US)

(74) Representative: Held, Stephan 
Meissner, Bolte & Partner GbR Widenmayerstraße 47
80538 München
80538 München (DE)

   


(54) INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING A PPI IN COMBINATION WITH AN IMMUNE TOLERANCE AGENT